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TheNa+-translocating NADH:quinone oxidoreductase (Na+-NQR) is
a component of the respiratory chain of various bacteria. This enzyme is
ananalogousbutnothomologous counterpart ofmitochondrial Complex
I. Na+-NQR drives the same chemistry and also uses released energy to
translocate ions across the membrane, but it pumps Na+ instead of H+.
The study of H+-pumps is hampered by the complexity of separation
between protons taking part in the catalytic redox reactions and the
protons involved in the transmembrane translocation process (pump-
ing). From that point of view, the investigation of the redox-driven
sodiumpumpgives a unique possibility to separate these ions, because in
this case the redox chemistry still requires protons, but the translocation
activity depends only on the presence of Na+. For example, for sodium-
translocating enzymes it is possible to resolve the events of the catalytic
cycle, which are slowed down at low concentrations of the coupling ion.
This approach reveals the specific transitions of the catalytic cycle
responsible for the sodium translocation. On the other hand, study of the
dependenceof the thermodynamic properties of a sodiumpumponNa+
concentration allows determination of the mechanism of conversion of
the redox energy into the sodium-motive force. The report will be
devoted tomodern knowledge on the structural and catalytic character-
istics of Na+-NQR and focused on the sodium dependence of the kinetic
and thermodynamic properties of the enzyme.
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Complex II (succinate–quinone reductase) is part of the mito-
chondrial and bacterial respiratory chain. The enzyme complex is
composed of a hydrophilic dehydrogenase domain composed of the
SdhA (flavoprotein) and SdhB (iron–sulfur protein) subunits. The
SdhAB subunits are bound to the membrane by two hydrophobic
subunits SdhC and SdhD which also form the site for attachment of
the heme b. There are two spatially separated catalytic sites in
complex II; one is the dicarboxylate binding site in SdhA where
succinate oxidation occurs and the other is in the hydrophobic
domain where quinone-reduction takes place. The two catalytic sites
communicate with each other through a series of three iron–sulfur
clusters in the SdhB subunit. Conserved amino acid residues from the
SdhB, SdhC, and SdhD subunits are involved in binding and stabilizing
the quinone. Mutation of one of these amino acids, SdhB His207,
results in changes in the redox properties of the [3Fe–4S] cluster
proximal to the quinone binding site. The structure of the SdhB
His207Thr mutant enzyme suggests that alteration of the hydrogen-
bonding pattern of the [3Fe–4S] cluster results in the lowering of the
redox potential of the iron–sulfur cluster. The mutant enzyme is still
able to bind quinones although there is about a 30% reduction in
steady state turnover activity. Electron transfer to the heme in the
mutant enzyme is altered by comparison with wild-type and the
SdhD His71Gln mutant enzyme. The latter has a lowered redox
potential for the heme b. The data suggest altered pathways for heme
reduction in wild-type and mutant enzymes.
The studies were supported by NIH grant GM61606 and the
Department of Veterans Affairs.
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Current tuberculosis (TB) treatment regimes depend on four
front-line anti-TB drugs: isoniazid, pyrazinamide, rifampin and
ethambutol, all developed in the 1950s–1960s. Coupled with the
slow growth of Mycobacterium tuberculosis (generation time about
24 h), means that chemotherapy is prolonged; current “short
course” treatment requires multi-drug therapy for 6–9 months.
New drugs are urgently needed, to shorten this period, to address
persistence, and to deal with the increasing incidence of multi- and
extensively-drug resistant TB. An area that is starting to attract
considerable interest for drug development is the metabolism and
bioenergetics of M. tuberculosis during persistence with the
realization that the entry into a persistent state is largely a meta-
bolic phenomenon. ATP generation by the membrane-bound F1FO-
ATP synthase is essential for growth and persistence in mycobacter-
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